Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-02-20
2010-06-29
Parkin, Jeffrey S (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S243000, C435S244000, C435S256800
Reexamination Certificate
active
07745157
ABSTRACT:
The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.
REFERENCES:
patent: 5747024 (1998-05-01), Grabstein et al.
patent: 6270758 (2001-08-01), Staats et al.
patent: 6406699 (2002-06-01), Wood
patent: 6416977 (2002-07-01), Becher
patent: 6432679 (2002-08-01), Mond et al.
patent: 6471957 (2002-10-01), Sim et al.
patent: 6475483 (2002-11-01), Steinman et al.
patent: 6479652 (2002-11-01), Crameri et al.
patent: 6605286 (2003-08-01), Steidler et al.
patent: 6664090 (2003-12-01), Silver et al.
patent: 2001/0006642 (2001-07-01), Steidler et al.
patent: 2001/0041180 (2001-11-01), Staats et al.
patent: 2002/0142352 (2002-10-01), Hunter et al.
patent: 2002/0182174 (2002-12-01), Hellstrand et al.
patent: 2003/0082232 (2003-05-01), Lee et al.
patent: 2003/0086900 (2003-05-01), Low et al.
patent: 2003/0099609 (2003-05-01), Sim et al.
patent: 2003/0187225 (2003-10-01), Penichet et al.
patent: 2003/0198643 (2003-10-01), Lu
patent: 2003/0216565 (2003-11-01), McCall et al.
patent: 0 105 749 (1984-04-01), None
patent: WO 03/039232 (2003-05-01), None
Baxevanis C. Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes. British Journal of Cancer 1997, vol. 76(8), pp. 1072-1080.
Santamaria P. Long term expansion of cytomegalovirus-specific T cell lines. Use of monosized polystyrene particles coated with agonistic antibodies. Journal of Immunological Methods 1990, vol. 132(1), pp. 1-11.
Mengozzi et al. Naïve CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells. Proceedings of the National Academy of Sciences of the United States of America (Washington, DC) Sep. 25, 2001. vol. 98. No. 20, p. 11644-11649.
Yee, C. Adoptive T cell therapy: addressing challenges in cancer immunotherapy. Journal of Translational Medicine Apr. 28, 2005, vol. 3, p. 17-24.
Meidenbauer et al. Generation of PSA-Reactive Effector Cells After Vaccination With a PSA-Based Vaccine in Patients With Prostate Cancer. The Prostate 2000, vol. 43, p. 88-100.
June et al. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes. The Journal of Immunology Jul. 1, 1989. vol. 143, No. 1, p. 153-161.
Quinn et al. T-Cell Activation Modulates Retrovirus-Mediated Gene Expression. Human Gene Therapy 1998, vol. 9, pp. 1457-1467.
G.T. Brice et al. “Development of an Animal Model for Autotransfusion Therapy: In Vitro Characterization and Analysis of Anti-CD3/CD28 Expanded Cells” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 19:210-220, 1998, Lippincott Williams & Wilkins, Phildelphia, USA.
Kato, K. et al.: “T-cell-conditioned medium efficiently induces the maturation and function of human dendritic cells.” Journal of Leukocyte Biology Dec. 2001, vol. 70, No. 6, Dec. 2001, pp. 941-949.
Morse M.A. et al: “Generation of Dendritic Cells In Vitro From Peripheral Blood Mononuclear Cells With Granulocyte-Macrophage-Colony-Stimulating Factor, Interleukin-4, and Tumor Necrosis Factor-alpha for Use in Cancer Immunotherapy.” Annals of Surgery Jul. 1997, vol. 226, No. 1 Jul. 1997, pp. 6-16.
Gallucci S. et al: “Natural adjuvants: Endogenous activators of dendritic cells.” Nature Medicine Nov. 1999, vol. 5, No. 11, Nov. 1999, pp. 1249-1255.
Sallusto F. et al.: “Distinct pattern and kinetics of chemokine production regulate dendritic cell function.” European Journal of Immunology May 1999, vol. 29, No. 5, May 1999, pp. 1617-1625.
Hankey Kim Graulich
Hasumi Kenichiro
Holt Kristina Michelle
Mann Dean LeMar
Hasumi LLC
Humphrey Louise
Parkin Jeffrey S
Thompson Hine LLP
University of Maryland Baltimore
LandOfFree
Human lymphocyte medium adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human lymphocyte medium adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human lymphocyte medium adjuvant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4233090